Global burden of musculoskeletal disorders in children and adolescents from 1990 to 2021: a joint point regression and decomposition analysis
- 27 August 2024
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 44 (10) , 2167-2177
Abstract
The study aimed to investigate the pattern and trend of Musculoskeletal (MSK) disorders in people aged 5–19 years from 1990 to 2021. The data was sourced from the Global Burden of Disease study 2021. The Age-standardized DALYs rates (ASDR), age-standardized mortality rate (ASMR), age-standardized prevalence rate (ASPR), and age-standardized incidence rate (ASIR) and their corresponding average annual percent change (AAPC) for MSK disorders were evaluated by sex, region, and sociodemographic index (SDI) quintiles. Globally, the ASPR of MSK disorders among children and adolescents increased per 100,000 population from 3048.66 (95% confidence interval [CI]: 2336.68–3887.02) in 1990 to 3105.46 (95% CI: 2421.09–3904.95) in 2021 (AAPC 0.06 [95% CI: 0.05–0.07]). In 2021, individuals aged 15–19 experienced the highest burden compared to those aged 5–9 and 10–14. In 2021, high SDI countries had the highest ASIR, ASPR, ASDR of MSK disorders. The AAPC of ASPR in high SDI countries showed a stark contrast to that in low SDI countries for the same period (AAPC 0.48 vs. AAPC −0.03). From 1990 to 2021, in low SDI and low-middle SDI countries, the increase in DALYs was primarily due to population growth. However, in middle SDI, high-middle, and high SDI countries, the increases were mainly due to epidemiological changes. Globally, patients aged 10–14 experienced better care compared to those in the 5–9 and 15–19 age groups. Specific preventive health measures are needed for females and adolescents aged 15–19 in high SDI countries.Keywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (82273710)
This publication has 29 references indexed in Scilit:
- Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort studyRheumatology International, 2024
- Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic reviewRheumatology International, 2024
- Pain catastrophizing in rheumatic diseases: prevalence, origin, and implicationsRheumatology International, 2024
- Systemic juvenile idiopathic arthritis: frequency and long-term outcome in Western AustraliaRheumatology International, 2023
- Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019Autoimmunity Reviews, 2023
- Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based reviewRheumatology International, 2022
- Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysisRheumatology International, 2021
- Rheumatoid arthritis: Extra-articular manifestations and comorbiditiesAutoimmunity Reviews, 2021
- Prevalence, Deaths, and Disability‐Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017Arthritis & Rheumatology, 2020
- Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017JAMA Pediatrics, 2019